Duration: (12:9) ?Subscribe5835 2025-02-28T06:23:43+00:00
Sangamo BioSciences CEO Edward Lanphier | Mad Money | CNBC
(8:20)
Sangamo Therapeutics on the New Frontiers of Genomic Medicine
(9:58)
Sangamo BioSciences
(14:18)
(12:58)
(18:18)
(17:15)
087 - Sangamo Therapeutics Leverages Pharma Partnerships for Success!
(39:15)
Sangamo Therapeutics
(14:52)
Sangamo Therapeutics CEO: Alzheimer's and Parkinson's Gene Therapies | Mad Money | CNBC
(6:26)
(16:58)
(15:39)
Sangamo BioSciences - Company Presentation
(12:9)
Sangamo Therapeutics CEO on partnering with Biogen to develop gene-regulation therapies for Alzheime
(6:56)
Genome editing - Sangamo Biosciences presentation | Cell \u0026 Gene Therapy Europe
(33:51)
Sangamo Therapeutics’ Focus on Rare Diseases
(2:9)
Company Presentation - Sangamo BioSciences, Inc.
(15:29)
Sangamo Therapeutics’ Isaac Young talks BIO Business Solutions®
(1:38)
Sangamo Gene Tests Inspired by One Man's AIDS 'Cure'
(3:1econd)
Crispr Therapeutics CEO: Science in gene editing is moving at break-neck speed
(3:39)
Life @ Moderna
(54)
10x Genomics and Illumina: Bringing Single Cell Gene Expression to Illumina Sequencing Platforms
(38:31)
Sangamo Therapeutics - Genomic Medicine
(10:23)
Welcome Remarks: Edward Lanphier, Chairman, ARM; President \u0026 CEO, Sangamo BioSciences
(8:34)